US OptionsDetailed Quotes

BIIB250502P122000

Watchlist

0.15
-0.97-86.61%

15min DelayClose May 2 16:00 ET

0.15High0.15Low

Biogen Stock Discussion

Teddy123

Apr 16 13:03

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

$Biogen (BIIB.US)$
Breakthrough: First-Ever Drug to Slow Early Alzheimer's Gets EU Green Light

Teddy123

Apr 1 19:55

Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.

$Organon & Co (OGN.US)$ $Biogen (BIIB.US)$
Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal

Teddy123

Mar 24 19:34

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

$Biogen (BIIB.US)$
Biogen's Bold Move: 580,000 sq ft Innovation Powerhouse to Transform Kendall Square Research Hub

Teddy123

Mar 11 19:35

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

$Biogen (BIIB.US)$
Biogen's Breakthrough Drug Enters Final Testing Phase for Critical Kidney Transplant Complication

ColdJoke

Mar 7 23:56

confirmed bottom

$Biogen (BIIB.US)$ confirmed technical bottom

thoughtful Bat_8163

Feb 12 22:41

$Biogen (BIIB.US)$ Leqembi sale 81 m, last quarter was 51 m. more than 50% higher. Third quarter (51m) was 30% higher than the second. Even though it is just a small percentage of the total revenue (2.46 billion), the sale of Leqembinis is accelerating

Moomoo News Global

Feb 5 21:04

Columns Tariff Investment Opportunities: Four Sectors as Potential Safe Havens

Over the weekend, President Donald Trump announced tariffs on the U.S.'s top three trading partners—Canada, Mexico, and China—and threatened similar measures against the EU. On Monday, U.S. stocks experienced a selloff, with the major indices dropping. Losses narrowed, however, after news broke of a delay in imposing tariffs on Mexico.
Market worries over the tariffs focus on two key issues. U.S. companies that depend heavily ...

Stock_Drift

Jan 27 09:58

$Biogen (BIIB.US)$

US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug

ColdJoke

Jan 23 22:17

massive layoff

$Biogen (BIIB.US)$ They have massive layoff on R&D side from social networking information. Middle term positive to stock price and shareholders. Source mentions like 50% cut in USA R&D, some teams are wiped out.

Moomoo Breakfast US

Jan 13 20:10

Columns US Morning News Call | US Strengthens Global Controls on AI Chip Exports

Expand

TSMC's Q4 Results Beat Expectations: Can its stock price reach a new high?

No comment yet